CGS-15435A

N/A

Report date: 2023/10/08 17:31:12

Base Information

Drug NameCGS-15435A
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThromboxane A2 synthase inhibitors
TargetsThromboxane A2 synthase
Therapy Area/IndicationsThromboembolismMyocardial Ischemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsThromboembolismMyocardial Ischemia

Other Information

ATC CodeN/A
Related LinksN/A